CN1578670B - 乳清脱辅基蛋白在预防或治疗微生物或病毒感染中的用途 - Google Patents

乳清脱辅基蛋白在预防或治疗微生物或病毒感染中的用途 Download PDF

Info

Publication number
CN1578670B
CN1578670B CN028210786A CN02821078A CN1578670B CN 1578670 B CN1578670 B CN 1578670B CN 028210786 A CN028210786 A CN 028210786A CN 02821078 A CN02821078 A CN 02821078A CN 1578670 B CN1578670 B CN 1578670B
Authority
CN
China
Prior art keywords
acid
whey
mixture
composition
apoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN028210786A
Other languages
English (en)
Chinese (zh)
Other versions
CN1578670A (zh
Inventor
M·A·福兰
D·布拉迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Westgat Biological S P A
Original Assignee
Westgat Biological S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westgat Biological S P A filed Critical Westgat Biological S P A
Publication of CN1578670A publication Critical patent/CN1578670A/zh
Application granted granted Critical
Publication of CN1578670B publication Critical patent/CN1578670B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
CN028210786A 2001-08-23 2002-08-20 乳清脱辅基蛋白在预防或治疗微生物或病毒感染中的用途 Expired - Fee Related CN1578670B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IES2001/0780 2001-08-23
IES20010780 2001-08-23
PCT/IE2002/000121 WO2003018049A2 (en) 2001-08-23 2002-08-20 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection

Publications (2)

Publication Number Publication Date
CN1578670A CN1578670A (zh) 2005-02-09
CN1578670B true CN1578670B (zh) 2013-09-04

Family

ID=11042830

Family Applications (1)

Application Number Title Priority Date Filing Date
CN028210786A Expired - Fee Related CN1578670B (zh) 2001-08-23 2002-08-20 乳清脱辅基蛋白在预防或治疗微生物或病毒感染中的用途

Country Status (15)

Country Link
US (2) US7687074B2 (https=)
EP (1) EP1427436B1 (https=)
JP (1) JP4532900B2 (https=)
KR (1) KR100907959B1 (https=)
CN (1) CN1578670B (https=)
AT (1) ATE399562T1 (https=)
AU (1) AU2002356112B2 (https=)
CA (1) CA2458146C (https=)
DE (1) DE60227389D1 (https=)
DK (1) DK1427436T3 (https=)
ES (1) ES2309228T3 (https=)
NZ (1) NZ531639A (https=)
PT (1) PT1427436E (https=)
RU (1) RU2305547C2 (https=)
WO (1) WO2003018049A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863168A1 (fr) * 2003-12-04 2005-06-10 Centre Nat Rech Scient Utilisation d'inducteurs de la voie de degradation de la gamma-butyrolactone pour inactiver le signal n-acy homoserine lactone.
BRPI0512864B8 (pt) * 2004-07-01 2021-05-25 Johnson & Johnson Vision Care composição oftálmica, uso de pelo menos um ácido graxo ômega-6 e pelo menos um ácido graxo ômega-3 e método para preparar a referida composição
WO2007035870A2 (en) * 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
WO2007061942A2 (en) 2005-11-18 2007-05-31 Glanbia Nutritionals (Ireland) Ltd. Compositions for disrupting and inhibiting reconstitution of wound biofilm
JP5017531B2 (ja) * 2006-09-11 2012-09-05 株式会社アップウェル 口内清浄剤
KR20100108526A (ko) * 2007-12-04 2010-10-07 웨스트게이트 바이올로지컬 리미티드 지방산 및 우유 단백질을 포함하는 항균성 조성물
JP2009190994A (ja) * 2008-02-13 2009-08-27 Kitasato Institute 抗インフルエンザウイルス剤、及びその有効成分の製造方法
US20090311236A1 (en) * 2008-06-11 2009-12-17 Immune @Work, Inc. Therapeutic Peptide Compositions And Methods Of Making And Using Same
EP2316445A4 (en) * 2008-06-11 2011-12-21 Ricom Corp HUMAN BETA3 ADRENERGER RECEPTOR LIGAND AND THEREOF FOOD OR PHARMACEUTICAL PREPARATION
US8808345B2 (en) * 2008-12-31 2014-08-19 Medtronic Ardian Luxembourg S.A.R.L. Handle assemblies for intravascular treatment devices and associated systems and methods
WO2010082587A1 (ja) * 2009-01-13 2010-07-22 株式会社大気倶楽部 空中懸濁物吸着剤
KR101119538B1 (ko) * 2009-06-10 2012-02-22 장선호 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방 및 치료용 조성물
ES2643862T3 (es) * 2009-11-17 2017-11-24 Michael Anthony Folan Composiciones antimicrobianas que contienen ácidos grasos libres
AR082943A1 (es) * 2010-08-06 2013-01-23 Aptalis Pharma Ltd Formula nutricional predigerida
KR101355018B1 (ko) * 2010-12-13 2014-01-24 노부오 구보 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방용 동물사료 첨가제 및 이를 포함하는 동물사료용 조성물
RU2494726C2 (ru) * 2011-04-11 2013-10-10 Общество с Ограниченной Ответственностью "Производственная Торговая Компания "Лактив" Способ профилактики и лечения грибковой инфекции у больных с голосовыми протезами
EP3150257A1 (en) * 2015-09-30 2017-04-05 Buga, Doris A method for producing a composition for strengthening the immune system
CA3026402A1 (en) 2017-12-05 2019-06-05 James F. Kane Water-soluble cannabinoids and methods of making same
US11298379B2 (en) * 2020-04-16 2022-04-12 James F. Kane Compositions comprising milk fat globules and methods of making same
CN113855787A (zh) * 2020-06-30 2021-12-31 北京大学 乳清蛋白作为冠状病毒广谱抑制剂的用途

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2796378A (en) * 1954-04-09 1957-06-18 Jr Edgar A Ferguson Methionine free reaction product of a water-soluble copper salt and lactalbumin hydrolysate as fungicide
GB1050756A (https=) * 1964-09-10 1900-01-01
US4397927A (en) * 1982-03-25 1983-08-09 Brog Roy A Imitation milk compositions and aqueous dispersions prepared therefrom
EP0210204B1 (de) 1985-01-18 1988-12-07 Kailash Kumar Dr. Prof. Gauri Proteinhydrolysate, verfahren zu ihrer herstellung und arzneimittel, die diese hydrolysate enthalten
JPS62249931A (ja) 1986-04-21 1987-10-30 Morinaga Milk Ind Co Ltd 抗菌性組成物
JPH085798B2 (ja) * 1987-02-02 1996-01-24 紀夫 多田 抗菌剤
DE69003014T2 (de) * 1989-06-07 1993-12-16 Kao Corp Essbare Öl-in-Wasser-Emulsion.
JP2673320B2 (ja) * 1990-01-25 1997-11-05 雪印乳業株式会社 う蝕原菌付着阻止剤
JPH04159232A (ja) * 1990-08-21 1992-06-02 Yakult Honsha Co Ltd 日和見感染症予防・治療用経口組成物
CA2094570A1 (en) 1992-05-27 1993-11-28 Jerome F. Trumbetas Enzymatic protein process and product
CA2148261A1 (en) 1992-10-30 1994-05-11 Jerry A. Peterson Anti-diarrheic product and method of treating rotavirus-associated infection
US5785984A (en) * 1993-02-05 1998-07-28 Kao Corporation Taste-modifying method and bitterness-decreasing method
US6197356B1 (en) * 1993-08-03 2001-03-06 Immunopath Profile, Inc. Process for preparing hypoallergenic foods
AU7792294A (en) * 1994-08-16 1996-03-07 Hemant Sabharwal Antibacterial composition containing multimeric alpha-lactalbumin
JP4233615B2 (ja) * 1996-08-22 2009-03-04 森永乳業株式会社 経口抗ヒト爪白癬及び／又は爪白癬以外のヒト足部白癬用医薬品
DE69824150T2 (de) 1997-01-09 2005-05-25 Morinaga Milk Industry Co. Ltd. Lactoferrin-tabletten
IE970541A1 (en) 1997-07-25 1999-01-27 Michael Anthony Folan Maternal immune secretions and their use in the treatment and/or prophylaxis of the buccal cavity
JP4129566B2 (ja) * 1997-09-05 2008-08-06 大塚製薬株式会社 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤
US6287590B1 (en) 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
AUPP051497A0 (en) 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
US6126955A (en) * 1998-04-16 2000-10-03 University Of Utah Research Foundation Apo-transferrin as a potent inhibitor of bacterial adhesion to biomaterials
ATE259654T1 (de) 1998-06-26 2004-03-15 Nutricia Nv Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
JP2000119257A (ja) * 1998-08-14 2000-04-25 Nippon Nohyaku Co Ltd ピリダジノン誘導体
GB9903584D0 (en) 1999-02-18 1999-04-07 Univ Leeds Modified calycins
JP3662445B2 (ja) * 1999-06-30 2005-06-22 花王株式会社 油中水型乳化油脂組成物
WO2002094035A1 (en) * 2001-05-23 2002-11-28 Nutricopia, Inc. Nutritional frozen dessert and methods of manufacture
US20030165606A1 (en) 2001-07-18 2003-09-04 Lasekan John B. Anti-regurgitation formula and uses thereof
EP1319407A1 (en) * 2001-12-14 2003-06-18 Montoie Import-Export S.A. Pharmaceutical composition for topical treatment of skin disorders and skin wounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
郭本恒.乳品化学 1.中国轻工业出版社,2001,第6页表1-3.
郭本恒.乳品化学 1.中国轻工业出版社,2001,第6页表1-3. *

Also Published As

Publication number Publication date
KR20040041579A (ko) 2004-05-17
DE60227389D1 (de) 2008-08-14
WO2003018049A2 (en) 2003-03-06
JP2005501863A (ja) 2005-01-20
CA2458146A1 (en) 2003-03-06
NZ531639A (en) 2006-02-24
EP1427436A2 (en) 2004-06-16
ES2309228T3 (es) 2008-12-16
KR100907959B1 (ko) 2009-07-16
EP1427436B1 (en) 2008-07-02
US7687074B2 (en) 2010-03-30
CA2458146C (en) 2012-07-24
US7972629B2 (en) 2011-07-05
RU2305547C2 (ru) 2007-09-10
AU2002356112B2 (en) 2007-11-08
US20050042299A1 (en) 2005-02-24
RU2004108040A (ru) 2005-09-27
CN1578670A (zh) 2005-02-09
WO2003018049A3 (en) 2003-11-06
JP4532900B2 (ja) 2010-08-25
PT1427436E (pt) 2008-09-08
US20100209526A1 (en) 2010-08-19
DK1427436T3 (da) 2008-10-13
ATE399562T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
US7972629B2 (en) Product comprising a combination of milk serum apoproteins and free fatty acids
AU2002356112A1 (en) Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
JP6505594B2 (ja) プロバイオティクス細菌
US8338363B2 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
RU2239439C2 (ru) Материнские иммунные выделения и их применение для лечения и/или профилактики болезненных состояний человека
CN109069593B (zh) 组合、治疗性用途和预防性用途
ES2964356T3 (es) Composición a base de una mezcla de factores biológicos aislados a partir de calostro y aceites vegetales ozonizados para su uso en el tratamiento de vaginitis y vaginosis
US20250295739A1 (en) Combination, therapeutic uses and prophylactic uses
JP2002087989A (ja) コラーゲンを主成分とする新陳代謝促進剤、免疫強化剤、生体諸機能低下予防改善剤及びこれらを含有する機能食品
JP4313767B2 (ja) ヘリコバクター・ピロリ剥離作用を有するポリペプチド
AU2012200889B2 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
Kristmundsdóttir et al. Lipids as active ingredients in pharmaceuticals, cosmetics and health foods
KR20240128192A (ko) 항염증 펩타이드 pn5를 포함하는 염증성 질환의 예방 또는 치료용 조성물
KR20050119083A (ko) 슈퍼옥사이드 디스뮤타제 및 선택적인 5-리폭시게나아제저해제를 포함하는 조성물 및 그 적용 방법
IL187120A (en) Casein-derived peptides and methods for their use in the herd's interface with milk
IL222486A (en) Casein-derived peptides and methods for using them to enhance milk cleanliness
IL222487A (en) Casein-derived peptides and methods for using them to increase milk yield

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20050209

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130904

Termination date: 20190820